These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 3514164)

  • 1. Corticosteroids in COPD. A clinical trial and reassessment of the literature.
    Eliasson O; Hoffman J; Trueb D; Frederick D; McCormick JR
    Chest; 1986 Apr; 89(4):484-90. PubMed ID: 3514164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of nonresponse to corticosteroids in stable chronic airflow limitation.
    Syed A; Hoeppner VH; Cockcroft DW
    Clin Invest Med; 1991 Feb; 14(1):28-34. PubMed ID: 2040103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aerosol beclomethasone in patients with steroid-responsive chronic obstructive pulmonary disease.
    Shim CS; Williams MH
    Am J Med; 1985 Apr; 78(4):655-8. PubMed ID: 3985039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic Corticosteroids in Chronic Obstructive Pulmonary Disease Exacerbations (SCCOPE): rationale and design of an equivalence trial. Veterans Administration Cooperative Trials SCCOPE Study Group.
    Erbland ML; Deupree RH; Niewoehner DE
    Control Clin Trials; 1998 Aug; 19(4):404-17. PubMed ID: 9683314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of steroid responsiveness in patients with chronic airflow obstruction.
    Stokes TC; Shaylor JM; O'Reilly JF; Harrison BD
    Lancet; 1982 Aug; 2(8294):345-8. PubMed ID: 6124757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of the 12 minute walking test in assessing the effect of oral steroid therapy in patients with chronic airways obstruction.
    O'Reilly JF; Shaylor JM; Fromings KM; Harrison BD
    Br J Dis Chest; 1982 Oct; 76(4):374-82. PubMed ID: 6758833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of prednisolone in chronic airflow limitation.
    Mitchell DM; Gildeh P; Rehahn M; Dimond AH; Collins JV
    Lancet; 1984 Jul; 2(8396):193-6. PubMed ID: 6146752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomised controlled trial of inhaled corticosteroids in patients with chronic obstructive pulmonary disease.
    Bourbeau J; Rouleau MY; Boucher S
    Thorax; 1998 Jun; 53(6):477-82. PubMed ID: 9713447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sputum eosinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease: a randomised controlled trial.
    Brightling CE; Monteiro W; Ward R; Parker D; Morgan MD; Wardlaw AJ; Pavord ID
    Lancet; 2000 Oct; 356(9240):1480-5. PubMed ID: 11081531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of high dose inhaled beclomethasone dipropionate, 750 micrograms and 1500 micrograms twice daily, and 40 mg per day oral prednisolone on lung function, symptoms, and bronchial hyperresponsiveness in patients with non-asthmatic chronic airflow obstruction.
    Weir DC; Burge PS
    Thorax; 1993 Apr; 48(4):309-16. PubMed ID: 8511727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhaled budesonide therapy for patients with stable COPD.
    Weiner P; Weiner M; Azgad Y; Zamir D
    Chest; 1995 Dec; 108(6):1568-71. PubMed ID: 7497762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of corticosteroids on bronchodilator action in chronic obstructive lung disease.
    Wempe JB; Postma DS; Breederveld N; Kort E; van der Mark TW; Koëter GH
    Thorax; 1992 Aug; 47(8):616-21. PubMed ID: 1412119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of reversibility of airway obstruction in patients with chronic obstructive airways disease.
    Nisar M; Walshaw M; Earis JE; Pearson MG; Calverley PM
    Thorax; 1990 Mar; 45(3):190-4. PubMed ID: 2330551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Standard and double dose ipratropium bromide and combined ipratropium bromide and inhaled metaproterenol in COPD.
    LeDoux EJ; Morris JF; Temple WP; Duncan C
    Chest; 1989 May; 95(5):1013-6. PubMed ID: 2523291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of long-term treatment with corticosteroids in COPD.
    Renkema TE; Schouten JP; Koëter GH; Postma DS
    Chest; 1996 May; 109(5):1156-62. PubMed ID: 8625660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controlled trial of oral prednisone in outpatients with acute COPD exacerbation.
    Thompson WH; Nielson CP; Carvalho P; Charan NB; Crowley JJ
    Am J Respir Crit Care Med; 1996 Aug; 154(2 Pt 1):407-12. PubMed ID: 8756814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison between inhaled salmeterol and theophylline in the short-term treatment of stable chronic obstructive pulmonary disease.
    Broseghini C; Testi R; Polese G; Tosatto R; Rossi A
    Pulm Pharmacol Ther; 2005; 18(2):103-8. PubMed ID: 15649852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Withdrawal of chronic systemic corticosteroids in patients with COPD: a randomized trial.
    Rice KL; Rubins JB; Lebahn F; Parenti CM; Duane PG; Kuskowski M; Joseph AM; Niewoehner DE
    Am J Respir Crit Care Med; 2000 Jul; 162(1):174-8. PubMed ID: 10903238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In chronic obstructive pulmonary disease, a combination of ipratropium and albuterol is more effective than either agent alone. An 85-day multicenter trial. COMBIVENT Inhalation Aerosol Study Group.
    Chest; 1994 May; 105(5):1411-9. PubMed ID: 8181328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response to oral corticosteroids in chronic airflow obstruction.
    Lam WK; So SY; Yu DY
    Br J Dis Chest; 1983 Apr; 77(2):189-98. PubMed ID: 6347233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.